The US Department of Justice has indicted three individuals for their involvement in various schemes to perpetrate fraud and money-laundering. The three accused defrauded Medicare, TRICARE and private insurance companies of over $180 million.
The defendants perpetrated these frauds between September 2011 and January 2016. They used various pharmacies to fraudulently formulate, dispense, ship and bill insurance companies for compound medications sold as topical creams and capsules.
They also allegedly bribed vendors, healthcare providers and beneficiaries to promote, prescribe and receive prescriptions for needless compound medications. To conceal the illegal proceeds, the defendants purchased assets, such as real estate and luxury automobiles.
